The relationship between anemia and quality of life in cancer patients Review uri icon

Overview

MeSH Major

  • Anemia
  • Neoplasms
  • Quality of Life

abstract

  • Anemia is a common occurrence in patients with cancer, and especially in those who undergo chemotherapy. Traditionally, significantly decreased hemoglobin levels have been considered to be < or = 8 g/dl and have been associated with physiologic manifestations. More recent data have shown that milder anemia (hemoglobin levels 10-12 g/dl) has functional consequences as well. This article reviews several community-based studies that have analyzed changes in hemoglobin concentrations, transfusion requirements, and QOL parameters in anemic patients with cancer before and after treatment with epoetin alfa. The results of these studies have been consistent and show an increase in hemoglobin and a reduction in transfusion requirements when compared with baseline. Furthermore, a relationship between increasing hemoglobin levels and an improvement in QOL is suggested that is independent of tumor response. Additional studies are evaluating the optimal hemoglobin levels for the greatest incremental improvement in QOL.

publication date

  • July 10, 2000

Research

keywords

  • Review

Identity

Language

  • eng

PubMed ID

  • 10896325

Additional Document Info

start page

  • 19

end page

  • 23

volume

  • 5

number

  • SUPPL. 2